Covaxin safe for 2-18 age group: BB study | India News
NEW DELHI: Bharat Biotech International Ltdon Friday said its Covid vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic for those in 2-18 years age group in phase II/III study. It conducted phase II/III,…